Skip to main content
. Author manuscript; available in PMC: 2024 Dec 10.
Published in final edited form as: Neurotoxicol Teratol. 2024 Jan 8;101:107317. doi: 10.1016/j.ntt.2023.107317

Table 2.

Challenged with ethanol CDR Neurochemistry by Region.

CDR Group Comparison Region Neurocomponent Main Effects Two-Way Interactions Three-way Interaction
Tol Age Drug Tol x Age Tol x Drug Age x Drug Tol x Age x Drug
ETOH Vs. Saline mPFC DA × × × × × × ×
NE *** *
5-HT *
DOPAC × × × × × × ×
HVA × × × × × × ×
3-MT × × × × × × ×
5-HIAA ***
DOPAC/DA Ratio × × × × × × ×
5-HIAA/5-HT Ratio # # #
NAc DA # ^
NE **
5-HT **
DOPAC * *
HVA #
3-MT × × × × × × ×
5-HIAA
DOPAC/DA Ratio ***
5-HIAA/5-HT Ratio **
dStr DA *** * *
NE *** *** ** #
5-HT ** *
DOPAC ** # ^
HVA ** #
3-MT # *
5-HIAA * *** *
DOPAC/DA Ratio *** ** *
5-HIAA/5-HT Ratio * ^
VTA DA
NE
5-HT
DOPAC ^
HVA * ^
3-MT × × × × × × ×
5-HIAA *
DOPAC/DA Ratio ^
5-HIAA/5-HT Ratio *

CDR Neurochemistry by Drug and Region. These tables present a representation of the significance threshold for each main effect and interaction of each neuro-component following repeated toluene and cumulative dosing. The “x” symbol represents that the component was below our detection threshold; the stars represent their typical cutoff thresholds of <0.001 (***), <0.01 (**), <0.05 (*); the “#” represents scores that fall above 0.05 but below 0.075 (e.g. 0.05 < score < 0.075); and lastly the “^” represents scores above 0.075 but <0.099 (e.g. 0.075 < score < 0.099). Table cells that don’t have a symbol in them were within the detection range but whose p-values fell above 0.1. Minimum value for inclusion was above 3 times the background (PCA) and was calculated using the curve created by a set of external standards for each component analyzed.